(PharmaNewsWire.Com, August 03, 2018 ) Global dermal fillers market was valued around USD 3.2 Billion in 2017, wider acceptance and popularity among young generation driving the market revenue growth
Dermal fillers are implants that are regulated as the medical devices by U.S.FDA. Dermal fillers are used as effective treatment for folds correction, wrinkles and deep lines on the face. Dermal fillers can be used for anti-aging practices to remove folds and wrinkles in nasolabial, and cheek area, lines and wrinkles around eye and volume loss in chin. Dermal fillers are the injectable gels that are composed of synthetic and natural substances like hyaluronic acid. Dermal fillers pump and lift the sagged skin for restoring lost collagen because of the aging.
Global Dermal Fillers Market Outline Increase in patients with different cosmetic skin issues like deep lines, wrinkles and scars, diet imbalance are the major factors boosting the revenue growth of the global dermal fillers market. As per the World Health Organization (WHO), more than 2 Bn of the global population will be over the age of 60 by the year 2050, WHO stated that the growth of the facial filler market is directly proportional to the growing geriatric population, who experience loss of fluid and collagen in the skin as they grow older, that results in the development of wrinkles on the face and neck areas. Dermal fillers is less painful and non-invasive method for treating various facial problems and aesthetic treatments for other parts of the body. High cost of the procedure and infections associated with dermal fillers is the major market constraint that hinders the growth of the dermal fillers (injectable fillers) market over the forecast period.
Dermal fillers market segmented on the basis of product type, ingredient and distribution channel On basis of product type, the global dermal fillers market is segmented into Absorbable Dermal Fillers Non-Absorbable Dermal Fillers
On basis of ingredient, the global dermal fillers market is segmented into Hyaluronic Acid (HLA) Poly-L-Lactic Acid (PLA) Calcium Hydroxylapatite (CaH) Polymethylmethacrylate (PMMA) Collagen Others
The global dermal fillers (Injectable Fillers) market is expected to grow at significant rate owing to advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing dermal fillers to patients. Further, the market is witnessing various acquisitions, collaborations, and mergers among major players. ANAMCS (The National Ambulatory Medical Care Survey) reported that from 1995 to 2003, soft tissue fillers 18.4% constituted office-based cosmetic procedure visits. 90% of office-based cosmetic procedures were performed on Caucasian patients and 10% on non-Caucasian patients. The American Society of Plastic Surgeons in its 2007 Cosmetic Demographics by Patient Ethnicity reported that injectable fillers are one of the three most commonly adopted procedures among, Hispanics, Asian Americans, and African-Americans who seeks cosmetic procedures. As per to the statistics of the American Society of Aesthetic Plastic Surgery, in 2015, dermal filler cosmetic treatments has increased by 8%.
Based on the geographical regions global injectable fillers market is segmented into five key regions Latin America, North America, Asia-Pacific, Europe, Middle East and Africa. North America holds largest share globally followed by Europe, and Asia Pacific due to the high occurrence of various skin problems. In Asia-Pacific, the Australian and China facial injectable fillers market will sustain the fastest growth through 2014. The Asia-Pacific facial injectable fillers market comprising sales of hyaluronic acid (HA) dermal fillers, particle and polymer fillers (PPFs), and collagen fillers will grow significantly due to increased physician adoption of profitable facial injectable treatments in their practices and growing patient demand for less invasive cosmetic procedures.
Some of the players in the global dermal fillers market are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), MERZ PHARMA GMBH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland), AQTIS Medical (Canada), and Suneva Medical (U.S.)
In January, 2017, Allergan plc. launched Juvederm First injectable filler designed for improving quality of skin and lasts up to 9 months with just one treatment session. This new innovative product of Allergan works with unique patented VYCROSS technology In December 2016, Galderma received U.S.FDA approval for two new products that are used to treat nasolabial folds or laugh lines in patients over the age of 21 In 2015, Allergan plc, received approval from the U.S.FDA approval to market its juvederm ultra xc injection used for lip augmentation in adults over the age of 21 In April 2014, Merz Aesthetics, introduced Belotero, innovative hyaluronic acid fillers, provided with and without lidocaine Buy Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-PBI-HnM-3155/
Report Outline: The report provides granular level information about the market size, regional market share and forecast from 2018-2024 The report covers in-detail insights about the competitor’s overview, key findings and their key strategies The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry The report tracks recent innovations, key developments and startup’s details that are working in the industry The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
